The webinar covers the current lessons learned from recent CF trials, barriers faced in today's research landscape, and several approaches to handle common issues.

The critical need for potent SARS-CoV-2 treatments has required acceleration of development timelines without compromising safety. Learn how one biotech company was able to administer the first human dose of a new antiviral just 23 days after first meeting with the CRO.

From revealing phenotypic and functional characterization of CAR T-cell products, along with mechanistic markers of efficacy and predictive markers of safety and response, biomarkers of all types play a central role in delivering critical insights that support informed decisions at every step of therapeutic development.

Over the last decade, an increasing number of drug development sponsors have conducted endometriosis clinical trials to explore more specific therapeutic targeting approaches for this chronic disease.

This video outlines challenges faced in the studies and helped streamline all aspects of the education, support, collection and shipment processes of biological samples.

There has been a growing body of supporting evidence in the translational research field showing the role genomic- and proteomic-based platforms in enabling more informed and potentially effective therapeutic strategies in clinical development and when appropriate transitioning to diagnostic applications. Hear from Labcorp Drug Development Sr.

Looking to better assess treatment benefit, drug developers for rare diseases are eager to incorporate remote monitoring solutions to complement the "snapshot" data collected at clinical visits and to collect richer data on how patients function at home.

Take a tour of our Greenfield, Indiana site to see how we are expanding our commitment to a sustainable future.

Xcellerate Access Intelligence Dashboard drives informed decisions with instant access to analytics for your patient support program.